Oncotarget

Research Papers:

The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas

Kai Dun Tang, Liz Kenny, Chris Perry, Ian Frazer and Chamindie Punyadeera _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:72272-72280. https://doi.org/10.18632/oncotarget.19731

Metrics: PDF 1398 views  |   HTML 2798 views  |   ?  


Abstract

Kai Dun Tang1,2, Liz Kenny3,4, Chris Perry5, Ian Frazer6 and Chamindie Punyadeera1,2

1The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland, Australia

2The Translational Research Institute, Woolloongabba, Australia

3School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia

4Central Integrated Regional Cancer Service, Queensland Health, Brisbane, Queensland, Australia

5Department of Otolaryngology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

6The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, Australia

Correspondence to:

Chamindie Punyadeera, email: [email protected]

Keywords: saliva, cytokeratin, head and neck squamous cell carcinoma, human papillomavirus

Received: May 17, 2017    Accepted: June 28, 2017    Published: July 31, 2017

ABSTRACT

Background: Cytokeratin (CK) intermediate filaments are demonstrated to have enormous potential in regulating cellular motility and cancer progression. There are more than 20 divergent CKs that have been identified, of which CK 8, 17, 18 and 19 are reported to be elevated in the tumour biopsies of head and neck cancer squamous cell carcinoma (HNSCC) patients. However, CK expression profiles in the saliva of HNSCC patients have not been investigated. We aim to investigate the mRNA expression profiles of CKs in saliva collected from healthy controls, HPV-negative and -positive HNSCC patients.

Methods: Oral rinse samples were collected from 42 cancer-free healthy controls (age-matched) and patients who have been diagnosed with HPV-negative (n = 20) and -positive (n = 48) HNSCC.

Results: Here, we report that the mRNA expression profiles of CKs differed in saliva collected from healthy controls and HNSCC patients. The mRNA expression levels of CK 8 and 18 were significantly elevated in saliva collected from HPV-negative HNSCC patients; whilst, CK 17 and 19 were expressed at a higher mRNA level in saliva collected from HPV-positive HNSCC patients compared to healthy controls. Importantly, receiver operating characteristic (ROC) analysis showed salivary CK 8 and 18 to have superior sensitivity and specificity in discriminating the HPV-negative HNSCC patients from healthy controls (80% and 86%) as well as between HPV-negative and -positive HNSCC patients (75% and 81%).

Conclusion: In summary, we have demonstrated that an aberrant expression of salivary CKs may serve as a potential non-invasive diagnostic biomarker in HNSCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19731